In recent years, the focus of research on human disease has shifted to the molecular level to determine genetic and proteome expression variations among humans as well as during disease development and progression. This trend, along with the many technological advances in the biomedical field, requires the availability of high-quality human specimen and accompanying clinical data. Therefore, a well-planned, quality-controlled biorepository is a critical resource in furthering the advances of biomedical discoveries. This article describes the considerations and decisions needed to obtain and store high-quality specimen and accompanying clinical data in a biorepository.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/bio.2010.0015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Spleen volume assessment in Ph-negative chronic myeloproliferative neoplasms: a real-life study comparing ultrasonography vs. magnetic resonance imaging scans.
Ann Hematol
January 2025
Hematology and Hematopoietic Stem Cell Transplant Center, Department of Medicine and Surgery, University of Naples Federico II, Via S. Pansini 5, Naples, 80131, Italy.
Splenomegaly is a quite common clinical feature of Philadelphia (Ph) negative chronic myeloproliferative neoplasms (MPNs) and its presence may, in some cases, drives treatment decision. Most importantly, palpable splenomegaly is a minor criterion for both pre-fibrotic/early primary myelofibrosis and primary myelofibrosis (PMF) diagnosis, even if clinical assessment by physical examination is poorly reliable and accurate. On the other hand, despite the International Working Group-Myeloproliferative Neoplasms Research and Treatment and European LeukemiaNet guidelines defined spleen response criteria by palpation, they also recognized the highly subjective nature of spleen size assessment by physical examination, and recommended objective confirmation of volume reduction via computed tomography or magnetic resonance imaging (MRI).
View Article and Find Full Text PDFNeutral hydrolysis of poly(ethylene terephthalate) catalysed by highly active terephthalate-based ionic liquids at low loadings.
Chem Commun (Camb)
January 2025
School of Chemistry, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse St., Dublin 2, Ireland.
Novel ionic liquid catalysts comprising terephthalate anions are capable of promoting the neutral hydrolysis of relatively large flake sizes of poly(ethylene terephthalate) at 0.5 mol% loading (200 °C, 4 h, 94% yield) without either attendant product inhibition or product contamination by protonated catalyst. Catalysts with large, lipophilic phosphonium cations outperform more polar variants.
View Article and Find Full Text PDFEnhanced superhydrophobic robustness of black silicon employing nanojungle structures.
Nanoscale
January 2025
Department of Chemistry and Materials Science, Tietotie 3, Espoo, 02150, Finland.
Superhydrophobic surfaces are essential in various industries such as textiles, aviation, electronics and biomedical devices due to their exceptional water-repellent properties. Black silicon (b-Si) would be an ideal candidate for some applications due to its nanoscale topography made with a convenient lithography-free step and complementary metal-oxide-semiconductor (CMOS) compatible fabrication process. However, its use is hindered by serious issues with mechanical robustness.
View Article and Find Full Text PDFAdvances in Organic Fluorescent and Colorimetric Probes for The Detection of Cu and Their Applications in Cancer Cell Imaging (2020-2024).
Crit Rev Anal Chem
January 2025
Department of Oral & Maxillofacial Surgery and Diagnostic Sciences, Faculty of Dentistry, Taif University, Taif, Saudi Arabia.
Organic fluorescence and colorimetric probes have emerged as vital tools for detecting metal ions, due to their high sensitivity, selectivity, and rapid response times. Copper, an essential trace element, plays a critical role in biological systems, yet its imbalance can lead to severe disorders such as neurodegenerative diseases, cancer, and Wilson's disease. Over the past few years, advancements in probe design have unlocked innovative avenues for not only detecting Cu in environmental and biological samples but also for visualizing its distribution through fluorescence imaging.
View Article and Find Full Text PDFA cost-effectiveness analysis of sotorasib as second-line treatment for patients with KRAS-G12C-mutated metastatic non-small cell lung cancer (mNSCLC) in Switzerland.
Swiss Med Wkly
January 2025
Cancer Center und Research Center, Cantonal Hospital Graubünden, Chur, Switzerland.
Background And Objective: Because of the lack of effective targeted treatment options, docetaxel has long been the standard second-line therapy for patients with advanced non-small cell lung cancer, including the Kirsten rat sarcoma virus (KRAS) G12C mutation. The CodeBreak 200 trial demonstrated that sotorasib, a new drug targeting the G12C-mutated KRAS protein, modestly improved progression-free survival compared with docetaxel in patients whose cancer had progressed after receiving platinum chemotherapy and programmed cell death protein 1 (PD-1) / programmed death ligand 1 (PD-L1) inhibitors as first-line treatment. Consequently, sotorasib received temporary approval in Switzerland.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!